Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. Mai 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., May 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Thursday, May 9, 2013 at 11:00 a.m....
24. April 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the Needham & Company 12th Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting...
13. März 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the fourth quarter and year ended December 31, 2012....
11. März 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the 25th Annual Roth Conference

SOUTH SAN FRANCISCO, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Adam R. Craig, M.D., Ph.D., Executive Vice President, Development and...
06. März 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Host Conference Call on March 13th to Discuss Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 6, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Wednesday, March 13th, 2013 at 11:00...
20. Februar 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at two...
06. Februar 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the Leerink Swann 2013 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President, Corporate Development and...
10. Januar 2013 16:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis Announces Clinical Trial Updates and 2013 Milestones at the 31st Annual JP Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, provided a corporate...
02. Januar 2013 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at...
20. November 2012 07:00 ET | Quelle: Sunesis Pharmaceuticals, Inc.

Sunesis to Present at the Piper Jaffray 24th Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting...

Vorherige Seite